DBDiana W. Bartenstein

Diana W. Bartenstein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Diana W. Bartenstein has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Language‐centered approach to care improvement in a pediatric dermatology clinic

    by Andrew R. Blundell, Danna Moustafa, Diana W. Bartenstein, Gideon P. Smith, Elena B. Hawryluk

    Language‐congruent care can improve clinical outcomes. As a quality improvement initiative supported by the Department of Dermatology at Massachusetts General Hospital, the American Academy of Dermatology, and the Society for Pediatric Dermatology, our group established monthly pediatric dermatology “Spanish clinics” that scheduled Spanish‐speaking patients on the same day and utilized a dedicated, live interpreter who stayed with the clinical team throughout the clinic. Patients reported high satisfaction scores, averaging 9.8 out of 10, and 90.5% of patients preferred this model to traditional appointments. Our participating physician found “Spanish clinics” allowed for more efficient care not only in the monthly pilot clinics, but in all clinics occurring during the time period.


  • Open Access

    Clinical features and outcomes of spitzoid proliferations in children and adolescents

    by D.W. Bartenstein, J.M. Fisher, C. Stamoulis, C. Weldon, J.T. Huang, S.E. Gellis, M.G. Liang, B. Schmidt, E.B. Hawryluk

    Background Spitzoid proliferations range from Spitz naevi to melanomas. There are few studies describing clinical features and outcomes in the paediatric population. Objectives To determine the clinical features and outcomes of a large paediatric cohort with histopathologically confirmed Spitz tumours. Methods This was a retrospective cohort study of patients seen at Boston Children's Hospital who were aged < 20 years and had a histopathological diagnosis of spitzoid proliferation from 1 January 1994 to 23 October 2012. Results In total 595 patients with 622 spitzoid proliferations were identified (median age 7·4 years, interquartile range 4·6–11·7). Overall 512 proliferations (82·3%) were typical, 107 (17·2.%) were atypical and three (0·5%) were melanomas. The median ages at biopsy were 7·4, 7·2 and 17·2 years, respectively, and there was a significant difference in age at biopsy for patients with typical or atypical proliferations vs. melanoma (P < 0·01). Among samples with positive margins (n = 153), 55% (54 of 98) of typical proliferations, 77% (41 of 53) of atypical proliferations and 100% (two of two) of melanomas were re‐excised. Six patients had sentinel lymph node biopsy performed, with three patients demonstrating nodes positive for melanocytic cells. Within a median follow‐up of 4·1 years for the full cohort there were no related deaths. Conclusions Spitz tumours have strikingly benign outcomes in the paediatric population, although this study is limited by the low number of melanomas and restriction to a single paediatric institution. Aggressive management recommendations should be reconsidered for children and adolescents with banal‐appearing Spitz naevi, based on the clinically indolent behaviour in this cohort.


  • Contrasting features of childhood and adolescent melanomas

    by Diana W. Bartenstein Ba, Cassandra M. Kelleher, Alison M. Friedmann, Lyn M. Duncan, Hensin Tsao, Arthur J. Sober, Elena B. Hawryluk

    Background/Objectives: Melanoma in children and adolescents is uncommon, and there are limited data on pediatric outcomes. Several studies have shown comparable survival rates in children and adults, but other research demonstrates that prepubescent children have more favorable outcomes. This study aims to compare childhood and adolescent melanoma.Methods: Retrospective cohort study of children who received a melanoma diagnosis at the Massachusetts General Hospital between January 1, 1995, and December 21, 2016. Childhood melanoma is defined as disease occurring in patients younger than 11 years old, and adolescent melanoma is defined as disease occurring in patients 11 to 19 years old. Patients diagnosed with ocular melanoma and borderline tumors of uncertain malignant potential were excluded. This analysis compares clinical, histopathologic, and outcome characteristics of childhood and adolescent melanoma.Results: Thirty‐two children with melanoma were identified (12 children, 20 adolescents). The spitzoid melanoma subtype was significantly more common in children (6/12) than adolescents (2/20) (P = .01). Four adolescents and no children with melanoma died from melanoma, and survival was significantly different between the age groups (P = .04). Median follow‐up time for survivors was 3.6 years.Conclusions: These results suggest that children and adolescents present with different melanoma subtypes and that adolescents have a more aggressive disease course than children.


  • Delayed‐type hypersensitivity to vaccine aluminum adjuvant causing subcutaneous leg mass and urticaria in a child

    by Samantha C. Gordon, Diana W. Bartenstein, Shahein H. Tajmir, Johanna S. Song, Elena B. Hawryluk

    A 3‐year‐old girl presented with a 7‐month history of a waxing and waning left thigh mass associated with pruritus and erythema at the site of two previous DTaP‐HepB‐IPV vaccinations. Patch testing was positive to aluminum chloride, supporting a diagnosis of vaccine granuloma secondary to aluminum allergy; her symptoms had been well controlled with antihistamines and topical steroids. Injection site granulomas are a benign but potentially bothersome reaction to aluminum‐containing immunizations that can be supportively managed, and we encourage strict adherence to the recommended vaccine schedule in this setting. Patch testing is a sensitive, noninvasive diagnostic tool for patients presenting with this clinical finding, and dermatologist awareness can prevent unnecessary medical examination and provide reassurance.


  • Congenital Nevi

    by Johanna S. Song, Diana Bartenstein, Elena B. Hawryluk

  • Open Access

    Evolving Childhood Melanoma Monitored by Parental Photodocumentation

    by Diana W. Bartenstein, Johanna S. Song, Rosalynn M. Nazarian, Elena B. Hawryluk